DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET ANALYSIS

Dental Membranes and Bone Graft Substitutes Market, By Product Type (Dental Membranes (Resorbable Membranes and Non-Resorbable Membranes) and Bone Graft Substitutes (Demineralized Bone Matrix (DBM), Allograft, Xenograft, Bovine Xenograft, Porcine Xenograft, and Synthetic Bone Graft Substitutes)), By Material Type (Hydrogel, Collagen, Human Cells Source, Other Species, Hydroxyapatite (HA), Tricalcium Phosphate (TCP), and Polytetrafluoroethylene), By End User (Hospitals, Dental Clinics, and Ambulatory Surgical Centers), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

In October 2023, ZimVie Inc., a global life sciences company, launched Biotivity A/C Plus Membrane in the U.S. It's a growth factor-rich barrier membrane for dental applications, aiding in jaw reconstruction and implant support. This move expands ZimVie's presence in dental biomaterials, focusing on wound healing enhancement.
In May 2022, BONESUPPORT AB, an orthobiologics company, announced the receipt of market authorization from the U.S. Food and Drug Administration for Cerament G. It is the first and sole bone graft substitute designed to fill gaps during surgical procedures and manage bone defects.
In Marh 2022, Molecular Matrix, Inc. (MMI), a regenerative medicine company, officially launched its Osteo-P Synthetic Bone Graft Substitute (BGS) designed for the musculoskeletal system. This innovative product utilizes MMI’s hyper-crosslinked carbohydrate polymer (HCCP) technology platform, initially developed to enhance stem cell research environments.
In January 2021, Dentsply Sirona Inc., a leading dental product manufacturer, announced its acquisition of Datum Dental, Ltd., a biotechnology company. This acquisition aims to advance dental regenerative procedures, enabling dental professionals to enhance patient care significantly.